Sergio Traversa

Insider · Chief Executive Officer · RLMD

Sergio Traversa files insider transactions with the SEC as a chief executive officer of Relmada Therapeutics. We hold 2 disclosed purchases and sales filed since 24 December 2013, 2 of them in the last 90 days.

Files for 2 companiesRLMD, ATNM
Disclosed buys and sells2 in all, 2 in the last 90 days
Last disclosure11 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 23 February 2015 — 10 September 2026Chief Executive Officer · Relmada Therapeutics 105 Form 4 lines · source: SEC Form 4
Filed 8 August 2013 — 14 March 2017Interim CFO · Actinium Pharmaceuticals 7 Form 4 lines · source: SEC Form 4

Every transaction

112 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing

Sort byOpen-market trades only112 of 112 shown


10 Sep 2026	11 Sep 2026SEC Form 4	1 d	bought on the open market	Relmada Therapeutics	100,000 shares	up +11.1%	up +0.0%
9 Sep 2026	11 Sep 2026SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	100,000 shares	up +10.5%	up +0.0%
15 Dec 2025	16 Dec 2025SEC Form 4	1 d	bought on the open market	Relmada Therapeutics	27,500 shares	up +3.7%	up +0.4%
12 Dec 2025	16 Dec 2025SEC Form 4	4 d	was grantednot a trade	Relmada Therapeuticsderivative	1,198,000 shares	up +11.3%	up +0.4%
5 Nov 2025	6 Nov 2025SEC Form 4	1 d	bought on the open market	Relmada Therapeutics	272,500 shares	up +80.1%	up +73.2%
28 Aug 2025	28 Aug 2025SEC Form 4	0 d	bought on the open market	Relmada Therapeutics	55,976 shares	up +483.2%	up +483.2%
27 Aug 2025	28 Aug 2025SEC Form 4	1 d	bought on the open market	Relmada Therapeutics	129,455 shares	up +574.6%	up +483.2%
26 Aug 2025	28 Aug 2025SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	80,545 shares	up +583.8%	up +483.2%
26 Jun 2025	30 Jun 2025SEC Form 4	4 d	was grantednot a trade	Relmada Therapeuticsderivative	800,000 shares	up +571.6%	up +653.3%
20 May 2025	20 May 2025SEC Form 4	0 d	bought on the open market	Relmada Therapeutics	147,686 shares	up +657.1%	up +657.1%
19 May 2025	20 May 2025SEC Form 4	1 d	bought on the open market	Relmada Therapeutics	30,000 shares	up +788.0%	up +657.1%
16 May 2025	20 May 2025SEC Form 4	4 d	bought on the open market	Relmada Therapeutics	172,314 shares	up +880.5%	up +657.1%
11 Sep 2024	11 Sep 2024SEC Form 4	0 d	bought on the open market	Relmada Therapeutics	51,407 shares	up +49.7%	up +49.7%
10 Sep 2024	11 Sep 2024SEC Form 4	1 d	bought on the open market	Relmada Therapeutics	33,014 shares	up +60.9%	up +49.7%
9 Sep 2024	11 Sep 2024SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	55,579 shares	up +62.0%	up +49.7%
24 May 2024	29 May 2024SEC Form 4	5 d	was grantednot a trade	Relmada Therapeuticsderivative	122,358 shares	up +48.2%	up +54.3%
24 May 2024	29 May 2024SEC Form 4	5 d	acquired or disposed of, othernot a trade	Relmada Therapeuticsderivative	122,358 shares	up +48.2%	up +54.3%
31 Jan 2024	31 Jan 2024SEC Form 4	0 d	bought on the open market	Relmada Therapeutics	27,460 shares	up +15.0%	up +15.0%
30 Jan 2024	31 Jan 2024SEC Form 4	1 d	bought on the open market	Relmada Therapeutics	40,999 shares	up +13.6%	up +15.0%
29 Jan 2024	31 Jan 2024SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	31,541 shares	up +21.5%	up +15.0%
15 Dec 2023	19 Dec 2023SEC Form 4	4 d	was grantednot a trade	Relmada Therapeuticsderivative	183,881 shares	up +82.3%	up +82.3%
25 May 2023	30 May 2023SEC Form 4	5 d	was grantednot a trade	Relmada Therapeuticsderivative	527,211 shares	up +59.2%	up +52.2%
16 Dec 2022	20 Dec 2022SEC Form 4	4 d	was grantednot a trade	Relmada Therapeuticsderivative	323,517 shares	up +34.1%	up +41.2%
16 Dec 2022	20 Dec 2022SEC Form 4	4 d	acquired or disposed of, othernot a trade	Relmada Therapeuticsderivative	300,000 shares	up +34.1%	up +41.2%
8 Dec 2022	12 Dec 2022SEC Form 4	4 d	bought on the open market	Relmada Therapeutics	55,250 shares	up +108.3%	up +33.3%
28 Sep 2022	6 Feb 2023SEC Form 4	131 d	gave awaynot a trade	Relmada Therapeuticsderivative	62,500 shares	down −87.0%	up +10.5%
28 Sep 2022	6 Feb 2023SEC Form 4	131 d	gave awaynot a trade	Relmada Therapeuticsderivative	87,500 shares	down −87.0%	up +10.5%
1 Jul 2022	5 Jul 2022SEC Form 4	4 d	exercised options overnot a trade	Relmada Therapeuticsderivative	13,755 shares	down −75.3%	down −76.5%
1 Jul 2022	5 Jul 2022SEC Form 4	4 d	exercised options overnot a trade	Relmada Therapeutics	13,755 shares	down −75.3%	down −76.5%
1 Jul 2022	5 Jul 2022SEC Form 4	4 d	sold on the open market	Relmada Therapeutics	839 shares	down −75.3%	down −76.5%
1 Jul 2022	5 Jul 2022SEC Form 4	4 d	sold on the open market	Relmada Therapeutics	8,848 shares	down −75.3%	down −76.5%
1 Jul 2022	5 Jul 2022SEC Form 4	4 d	sold on the open market	Relmada Therapeutics	4,068 shares	down −75.3%	down −76.5%
30 Jun 2022	5 Jul 2022SEC Form 4	5 d	exercised options overnot a trade	Relmada Therapeuticsderivative	16,012 shares	down −76.2%	down −76.5%
30 Jun 2022	5 Jul 2022SEC Form 4	5 d	exercised options overnot a trade	Relmada Therapeutics	16,012 shares	down −76.2%	down −76.5%
30 Jun 2022	5 Jul 2022SEC Form 4	5 d	sold on the open market	Relmada Therapeutics	5,314 shares	down −76.2%	down −76.5%
30 Jun 2022	5 Jul 2022SEC Form 4	5 d	sold on the open market	Relmada Therapeutics	10,698 shares	down −76.2%	down −76.5%
25 May 2022	26 May 2022SEC Form 4	1 d	was grantednot a trade	Relmada Therapeuticsderivative	651,821 shares	down −76.5%	down −75.8%
25 May 2022	26 May 2022SEC Form 4	1 d	was grantednot a trade	Relmada Therapeuticsderivative	300,000 shares	down −76.5%	down −75.8%
17 Dec 2021	21 Dec 2021SEC Form 4	4 d	was grantednot a trade	Relmada Therapeuticsderivative	492,173 shares	down −76.2%	down −78.4%
8 Jul 2021	6 Feb 2023SEC Form 4	578 d	gave awaynot a trade	Relmada Therapeuticsderivative	4,131 shares	down −86.0%	up +10.5%
8 Jul 2021	6 Feb 2023SEC Form 4	578 d	gave awaynot a trade	Relmada Therapeuticsderivative	27,123 shares	down −86.0%	up +10.5%
8 Jul 2021	6 Feb 2023SEC Form 4	578 d	gave awaynot a trade	Relmada Therapeuticsderivative	8,231 shares	down −86.0%	up +10.5%
8 Jul 2021	6 Feb 2023SEC Form 4	578 d	gave awaynot a trade	Relmada Therapeuticsderivative	131,250 shares	down −86.0%	up +10.5%
8 Jul 2021	6 Feb 2023SEC Form 4	578 d	gave awaynot a trade	Relmada Therapeuticsderivative	31,250 shares	down −86.0%	up +10.5%
8 Jul 2021	2 Feb 2023SEC Form 4	574 d	gave awaynot a trade	Relmada Therapeuticsderivative	4,131 shares	down −86.0%	up +5.9%
8 Jul 2021	2 Feb 2023SEC Form 4	574 d	gave awaynot a trade	Relmada Therapeuticsderivative	27,123 shares	down −86.0%	up +5.9%
8 Jul 2021	2 Feb 2023SEC Form 4	574 d	gave awaynot a trade	Relmada Therapeuticsderivative	8,231 shares	down −86.0%	up +5.9%
8 Jul 2021	2 Feb 2023SEC Form 4	574 d	gave awaynot a trade	Relmada Therapeuticsderivative	131,250 shares	down −86.0%	up +5.9%
8 Jul 2021	2 Feb 2023SEC Form 4	574 d	gave awaynot a trade	Relmada Therapeuticsderivative	93,750 shares	down −86.0%	up +5.9%
8 Jul 2021	2 Feb 2023SEC Form 4	574 d	gave awaynot a trade	Relmada Therapeuticsderivative	87,500 shares	down −86.0%	up +5.9%
10 Mar 2021	11 Mar 2021SEC Form 4	1 d	sold on the open market	Relmada Therapeutics	2,983 shares	down −87.0%	down −87.4%
9 Mar 2021	11 Mar 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeutics	10,000 shares	down −87.0%	down −87.4%
9 Mar 2021	11 Mar 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	5,217 shares	down −87.0%	down −87.4%
9 Mar 2021	11 Mar 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	1,800 shares	down −87.0%	down −87.4%
9 Mar 2021	11 Mar 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeuticsderivative	10,000 shares	down −87.0%	down −87.4%
24 Feb 2021	26 Feb 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeuticsderivative	10,000 shares	down −86.9%	down −86.4%
24 Feb 2021	26 Feb 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeutics	10,000 shares	down −86.9%	down −86.4%
24 Feb 2021	26 Feb 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	4,837 shares	down −86.9%	down −86.4%
24 Feb 2021	26 Feb 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	4,860 shares	down −86.9%	down −86.4%
24 Feb 2021	26 Feb 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	303 shares	down −86.9%	down −86.4%
11 Feb 2021	16 Feb 2021SEC Form 4	5 d	exercised options overnot a trade	Relmada Therapeutics	1,446 shares	down −87.5%	down −88.2%
11 Feb 2021	16 Feb 2021SEC Form 4	5 d	sold on the open market	Relmada Therapeutics	1,446 shares	down −87.5%	down −88.2%
11 Feb 2021	16 Feb 2021SEC Form 4	5 d	exercised options overnot a trade	Relmada Therapeuticsderivative	1,446 shares	down −87.5%	down −88.2%
10 Feb 2021	10 Feb 2021SEC Form 4	0 d	sold on the open market	Relmada Therapeutics	1,930 shares	down −87.1%	down −87.1%
9 Feb 2021	10 Feb 2021SEC Form 4	1 d	sold on the open market	Relmada Therapeutics	5,963 shares	down −87.1%	down −87.1%
8 Feb 2021	10 Feb 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeutics	11,206 shares	down −87.1%	down −87.1%
8 Feb 2021	10 Feb 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	3,313 shares	down −87.1%	down −87.1%
8 Feb 2021	10 Feb 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeuticsderivative	11,206 shares	down −87.1%	down −87.1%
3 Feb 2021	4 Feb 2021SEC Form 4	1 d	sold on the open market	Relmada Therapeutics	100 shares	down −86.9%	down −86.6%
2 Feb 2021	4 Feb 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeutics	3,278 shares	down −87.1%	down −86.6%
2 Feb 2021	4 Feb 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	3,178 shares	down −87.1%	down −86.6%
2 Feb 2021	4 Feb 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeuticsderivative	3,278 shares	down −87.1%	down −86.6%
2 Feb 2021	4 Feb 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeutics	13,281 shares	down −87.1%	down −86.6%
2 Feb 2021	4 Feb 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeuticsderivative	13,281 shares	down −87.1%	down −86.6%
27 Jan 2021	29 Jan 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeuticsderivative	10,000 shares	down −85.7%	down −86.2%
27 Jan 2021	29 Jan 2021SEC Form 4	2 d	exercised options overnot a trade	Relmada Therapeutics	10,000 shares	down −85.7%	down −86.2%
27 Jan 2021	29 Jan 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	4,351 shares	down −85.7%	down −86.2%
27 Jan 2021	29 Jan 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	5,549 shares	down −85.7%	down −86.2%
27 Jan 2021	29 Jan 2021SEC Form 4	2 d	sold on the open market	Relmada Therapeutics	100 shares	down −85.7%	down −86.2%
26 Jan 2021	26 Jan 2021SEC Form 4	0 d	sold on the open market	Relmada Therapeutics	600 shares	down −86.9%	down −86.9%
25 Jan 2021	26 Jan 2021SEC Form 4	1 d	sold on the open market	Relmada Therapeutics	1,300 shares	down −87.3%	down −86.9%
22 Jan 2021	26 Jan 2021SEC Form 4	4 d	exercised options overnot a trade	Relmada Therapeuticsderivative	4,070 shares	down −87.3%	down −86.9%
22 Jan 2021	26 Jan 2021SEC Form 4	4 d	exercised options overnot a trade	Relmada Therapeutics	4,070 shares	down −87.3%	down −86.9%
22 Jan 2021	26 Jan 2021SEC Form 4	4 d	sold on the open market	Relmada Therapeutics	1,736 shares	down −87.3%	down −86.9%
22 Jan 2021	26 Jan 2021SEC Form 4	4 d	sold on the open market	Relmada Therapeutics	434 shares	down −87.3%	down −86.9%
7 Jan 2021	11 Jan 2021SEC Form 4	4 d	was grantednot a trade	Relmada Therapeuticsderivative	250,000 shares	down −87.2%	down −87.1%
7 Jan 2021	11 Jan 2021SEC Form 4	4 d	was grantednot a trade	Relmada Therapeuticsderivative	250,000 shares	down −87.2%	down −87.1%
18 Aug 2020	19 Aug 2020SEC Form 4	1 d	exercised options overnot a trade	Relmada Therapeuticsderivative	50,008 shares	down −88.6%	down −88.6%
18 Aug 2020	19 Aug 2020SEC Form 4	1 d	exercised options overnot a trade	Relmada Therapeutics	50,008 shares	down −88.6%	down −88.6%
18 Aug 2020	19 Aug 2020SEC Form 4	1 d	had shares withheld for taxnot a trade	Relmada Therapeutics	4,151 shares	down −88.6%	down −88.6%
19 Dec 2019	23 Dec 2019SEC Form 4	4 d	was grantednot a trade	Relmada Therapeuticsderivative	350,000 shares	down −89.6%	down −89.3%
29 Jul 2019	30 Jul 2019SEC Form 4	1 d	was grantednot a trade	Relmada Therapeuticsderivative	1,700,000 shares	down −48.6%	down −46.9%
20 Dec 2018	20 Dec 2018SEC Form 4	0 d	was grantednot a trade	Relmada Therapeuticsderivative	900,000 shares	down −1.7%	down −1.7%
19 Oct 2017	23 Oct 2017SEC Form 4	4 d	was grantednot a trade	Relmada Therapeuticsderivative	850,000 shares	up +13.0%	up +32.9%
14 Mar 2017	16 Mar 2017SEC Form 4	2 d	was grantednot a trade	Actinium Pharmaceuticalsderivative	75,000 shares	—	—
15 Apr 2016	18 Apr 2016SEC Form 4	3 d	bought on the open market	Actinium Pharmaceuticals	1,000 shares	—	—
15 Apr 2016	18 Apr 2016SEC Form 4	3 d	was grantednot a trade	Actinium Pharmaceuticalsderivative	75,000 shares	—	—
14 Apr 2016	18 Apr 2016SEC Form 4	4 d	bought on the open market	Actinium Pharmaceuticals	2,000 shares	—	—
15 Dec 2015	17 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	241 shares	down −64.7%	down −65.2%
15 Dec 2015	17 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	2,759 shares	down −64.7%	down −65.2%
15 Dec 2015	17 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	2,370 shares	down −64.7%	down −65.2%
15 Dec 2015	17 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	5,600 shares	down −64.7%	down −65.2%
15 Dec 2015	17 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	4,358 shares	down −64.7%	down −65.2%
15 Dec 2015	17 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	1,600 shares	down −64.7%	down −65.2%
15 Dec 2015	17 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	42 shares	down −64.7%	down −65.2%
15 Dec 2015	17 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	200 shares	down −64.7%	down −65.2%
15 Dec 2015	17 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	1,800 shares	down −64.7%	down −65.2%
14 Dec 2015	16 Dec 2015SEC Form 4	2 d	bought on the open market	Relmada Therapeutics	30 shares	down −62.3%	down −69.5%
23 Feb 2015	5 Mar 2015SEC Form 4	10 d	was grantednot a trade	Relmada Therapeuticsderivative	225,000 shares	down −91.6%	down −91.3%
18 Feb 2015	16 Mar 2015SEC Form 4	26 d	was grantednot a trade	Actinium Pharmaceuticalsderivative	25,000 shares	—	—
8 Aug 2013	24 Dec 2013SEC Form 4	138 d	was grantednot a trade	Actinium Pharmaceuticalsderivative	20,000 shares	—	—
8 Aug 2013	24 Dec 2013SEC Form 4	138 d	was grantednot a trade	Actinium Pharmaceuticals	10,000 shares	—	—

Both percentages are the stock’s move, not Sergio Traversa’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 105 of the 112 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.